Background
Methods
Study population
Measurements and surveys
Statistical analysis
Results
Baseline characteristics
Variables | Men | Women |
P-value
|
---|---|---|---|
(n = 3636) | (n = 4072) | ||
Age, years | 51.4 ± 8.6 | 52.0 ± 8.9 | 0.0011 |
Current Smoker, n(%) | 1753 (48.2) | 142 (3.5) | <.0001 |
Current Drinker, n(%) | 2580 (71.0) | 1085 (26.7) | <.0001 |
Hypertension, n(%) | 1074 (29.5) | 1101 (27.0) | 0.0149 |
Family history of diabetes, n(%) | 333 (9.2) | 449 (11.0) | 0.0067 |
Regular exercise, n(%) | 1712 (47.1) | 1654 (40.6) | <.0001 |
BMI, kg/m2 | 24.1 ± 2.9 | 24.7 ± 3.2 | <.0001 |
WC, cm | 83.3 ± 7.6 | 81.2 ± 9.5 | <.0001 |
TG, mg/dl | 170.8 ± 111.6 | 140.9 ± 75.6 | <.0001 |
TyG index | 8.7 ± 0.5 | 8.5 ± 0.5 | <.0001 |
LAP | 38.1 ± 34.0 | 39.0 ± 30.6 | 0.1925 |
SBP, mmHg | 121.2 ± 16.6 | 119.9 ± 19.1 | 0.0029 |
DBP, mmHg | 81.6 ± 10.8 | 78.5 ± 11.6 | <.0001 |
FPG, mg/dl | 84.5 ± 9.0 | 81.1 ± 7.7 | <.0001 |
2hPG, mg/dl | 110.5 ± 32.0 | 117.2 ± 28.3 | <.0001 |
Total cholesterol, mg/dl | 190.3 ± 34.6 | 188.9 ± 33.9 | 0.0670 |
HDL-C, mg/dl | 43.8 ± 10.0 | 46.0 ± 10.0 | <.0001 |
LDL-C, mg/dl | 112.4 ± 34.2 | 114.7 ± 30.7 | 0.0017 |
HbA1c, mg/dl | 5.6 ± 0.3 | 5.5 ± 0.4 | 0.1636 |
Incidence of T2DM according to each index category
Categories | Men (n = 3636) | Women (n = 4072) | ||
---|---|---|---|---|
Quartile | Diabetes (%) | Quartile | Diabetes (%) | |
WC (cm) | Q1 (< 78.0) | 143 (16.4) | Q1 (< 74.0) | 128 (13.4) |
Q2 (78.0–83.2) | 162 (17.6) | Q2 (74.0–80.6) | 198 (18.1) | |
Q3 (83.3–88.2) | 207 (22.3) | Q3 (80.7–87.8) | 222 (22.2) | |
Q4 (≥88.3) | 254 (27.7) | Q4 (≥87.9) | 249 (24.5) | |
TG (mg/dl) | Q1 (< 106.0) | 137 (15.2) | Q1 (< 92.5) | 126 (12.4) |
Q2 (106.0–142.9) | 167 (18.4) | Q2 (92.5–121.9) | 136 (13.6) | |
Q3 (143.0–200.9) | 196 (21.5) | Q3 (122.0–165.9) | 225 (21.9) | |
Q4 (≥201.0) | 266 (29.0) | Q4 (≥166.0) | 310 (30.3) | |
FPG (mg/dl) | Q1 (< 78.0) | 106 (12.9) | Q1 (< 76.0) | 133 (13.9) |
Q2 (78.0–82.9) | 132 (14.7) | Q2 (76.0–79.9) | 143 (16.3) | |
Q3 (83.0–89.9) | 190 (19.5) | Q3 (80.0–84.9) | 206 (18.3) | |
Q4 (≥90.0) | 338 (35.9) | Q4 (≥85.0) | 315 (28.4) | |
LAP | Q1 (< 16.7) | 137 (15.1) | Q1 (< 18.8) | 126 (12.4) |
Q2 (16.7–29.4) | 140 (15.4) | Q2 (18.8–30.7) | 167 (16.4) | |
Q3 (29.5–49.1) | 212 (23.3) | Q3 (30.8–50.1) | 190 (18.7) | |
Q4 (≥49.2) | 277 (30.5) | Q4 (≥50.2) | 314 (30.8) | |
TyG index | Q1 (< 8.4) | 121 (13.3) | Q1 (< 8.2) | 113 (11.1) |
Q2 (8.4–8.6) | 153 (16.8) | Q2 (8.2–8.4) | 140 (13.8) | |
Q3 (8.7–9.0) | 206 (22.7) | Q3 (8.5–8.7) | 229 (22.5) | |
Q4 (≥9.1) | 286 (31.5) | Q4 (≥8.8) | 315 (30.9) |
Cut-off points of each index for predicting T2DM
Index | AROC (95% CI) | Cut-off point | Sensitivity (%) | Specificity (%) | Youden index |
---|---|---|---|---|---|
Men | |||||
WC (cm) | 0.579 (0.563–0.595) | 84.00 | 56.01 | 57.11 | 0.13 |
TG (mg/dl) | 0.592 (0.576–0.608) | 172.00 | 46.74 | 67.84 | 0.15 |
FPG (mg/dl) | 0.660 (0.645–0.676) | 87.00 | 51.31 | 72.89 | 0.24 |
LAP | 0.602 (0.586–0.618) | 30.50 | 62.79 | 55.54 | 0.18 |
TyG index | 0.623 (0.607–0.638) | 8.86 | 52.09 | 66.59 | 0.19 |
Women | |||||
WC (cm) | 0.576 (0.561–0.592) | 78.17 | 69.26 | 43.54 | 0.13 |
TG (mg/dl) | 0.627 (0.612–0.642) | 122.00 | 66.37 | 54.41 | 0.21 |
FPG (mg/dl) | 0.599 (0.584–0.614) | 84.00 | 39.52 | 75.69 | 0.15 |
LAP | 0.623 (0.607–0.637) | 35.84 | 57.59 | 61.59 | 0.19 |
TyG index | 0.644 (0.629–0.659) | 8.52 | 67.25 | 55.85 | 0.23 |
Odds ratios for incident T2DM for each composite predictive model
Categories | Unadjusted | Adjusteda) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
WC | TG | FPG | LAP | TyG index | WC | TG | FPG | LAP | TyG index | |
ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | |
Men | ||||||||||
Q1 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
Q2 | 1.09 (0.85–1.39) | 1.26 (0.99–1.62) | 1.16 (0.88–1.53) | 1.03 (0.79–1.33) | 1.32 (1.02–1.70) | 1.07 (0.81–1.40) | 1.21 (0.94–1.55) | 1.18 (0.89–1.56) | 1.04 (0.79–1.36) | 1.26 (0.97–1.64) |
Q3 | 1.46 (1.15–1.85) | 1.54 (1.21–1.95) | 1.64 (1.27–2.12) | 1.71 (1.35–2.18) | 1.91 (1.49–2.45) | 1.35 (1.00–1.83) | 1.39 (1.08–1.79) | 1.68 (1.29–2.19) | 1.70 (1.28–2.25) | 1.82 (1.41–2.36) |
Q4 | 1.95 (1.55–2.46) | 2.29 (1.82–2.88) | 3.78 (2.96–4.82) | 2.47 (1.96–3.11) | 2.99 (2.36–3.79) | 1.64 (1.13–2.38) | 2.03 (1.59–2.61) | 3.85 (2.99–4.97) | 2.47 (1.82–3.34) | 2.79 (2.16–3.60) |
Women | ||||||||||
Q1 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
Q2 | 1.43 (1.12–1.82) | 1.11 (0.86–1.44) | 1.20 (0.93–1.55) | 1.39 (1.08–1.78) | 1.28 (0.98–1.66) | 1.14 (0.88–1.48) | 1.02 (0.78–1.33) | 1.18 (0.91–1.53) | 1.26 (0.97–1.64) | 1.19 (0.91–1.55) |
Q3 | 1.86 (1.46–2.36) | 1.98 (1.56–2.51) | 1.38 (1.09–1.75) | 1.63 (1.27–2.07) | 2.32 (1.82–2.97) | 1.27 (0.95–1.69) | 1.69 (1.32–2.16) | 1.32 (1.04–1.68) | 1.35 (1.03–1.78) | 1.97 (1.53–2.53) |
Q4 | 2.10 (1.66–2.66) | 3.07 (2.44–3.87) | 2.45 (1.95–3.06) | 3.15 (2.51–3.97) | 3.59 (2.83–4.55) | 1.17 (0.83–1.65) | 2.42 (1.90–3.08) | 2.15 (1.71–2.71) | 2.44 (1.82–3.26) | 2.85 (2.22–3.66) |
Effects of the addition of each index to the basic model of T2DM on cNRI, IDI, and AROC
Parameter | Men | Women | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
AROC | p-value* | cNRI | p-value | IDI | p-value | AROC | p-value* | cNRI | p-value | IDI | p-value | |
Basic modela) | 0.615 | 0.621 | ||||||||||
Basic model + WC | 0.619 | 0.1176 | 0.056 | 0.1689 | 0.002 | 0.0140 | 0.621 | 0.3233 | −0.023 | 0.5666 | 0.000 | 1.0000 |
Basic model + TG | 0.632 | <.0001 | 0.227 | <.0001 | 0.007 | <.0001 | 0.652 | <.0001 | 0.286 | <.0001 | 0.019 | <.0001 |
Basic model + FPG | 0.692 | <.0001 | 0.480 | <.0001 | 0.064 | <.0001 | 0.652 | <.0001 | 0.214 | <.0001 | 0.018 | <.0001 |
Basic model + LAP | 0.634 | <.0001 | 0.236 | <.0001 | 0.007 | <.0001 | 0.644 | <.0001 | 0.213 | <.0001 | 0.016 | <.0001 |
Basic model + TyG index | 0.656 | <.0001 | 0.387 | <.0001 | 0.023 | <.0001 | 0.666 | <.0001 | 0.360 | <.0001 | 0.029 | <.0001 |